We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A revision was made with the goal of striking a balance between transparent interactions and the need for healthcare professionals to “make independent decisions regarding patient care and treatment.” Read More
A new IVD application for priority review status should include a justification for how early market availability in the country will result in improved health. Read More
The shift to increased patient input for device development and clinical trials in recent years has been more challenging than expected, according to participants at the FDA/CMS Summit. Read More
Hand Biomechanics Lab, a manufacturer of bone fixation fastener systems in Sacramento, California, was hit with an FDA warning letter for failing to submit MDRs and for GMP nonconformities. Read More